Mustafa Reem A, Wiercioch Wojtek, Arevalo-Rodriguez Ingrid, Cheung Adrienne, Prediger Barbara, Ivanova Liudmila, Ventresca Matthew, Brozek Jan, Santesso Nancy, Bossuyt Patrick, Garg Amit X, Lloyd Nancy, Lelgemann Monika, Bühler Diedrich, Schünemann Holger J
Department of Health Research Methods, Evidence and Impact (formerly "Clinical Epidemiology and Biostatistics"), McMaster University, Hamilton, Canada; Department of Internal Medicine, University of Kansas Medical Center, Kansas City, USA.
Department of Health Research Methods, Evidence and Impact (formerly "Clinical Epidemiology and Biostatistics"), McMaster University, Hamilton, Canada.
J Clin Epidemiol. 2017 Dec;92:38-46. doi: 10.1016/j.jclinepi.2017.09.004. Epub 2017 Sep 14.
The objective of the study was to describe and compare current practices in developing guidelines about the use of healthcare-related tests and diagnostic strategies (HCTDS).
We sampled 37 public health and clinical practice guidelines about HCTDS from various sources without language restrictions.
Detailed descriptions of the systems used to assess the quality of evidence and develop recommendations were challenging to find within guidelines. We observed much variability among and within organizations with respect to how they develop recommendations about HCTDS. Twenty-four percent of the guidelines did not consider health benefits and harms but based decisions solely on test accuracy. We did not identify guidelines that described the main potential care pathways involving tests for a healthcare problem. In addition, we did not identify guidelines that systematically assessed, described, and referenced the evidence that linked test accuracy and patient-important outcomes.
There is considerable variability among the processes used and factors considered in developing recommendations about the use of tests. This variability may be the cause for the disagreement we observed in recommendations about testing for the same condition.
本研究的目的是描述和比较制定有关医疗相关检查和诊断策略(HCTDS)指南的当前做法。
我们从各种来源抽取了37份关于HCTDS的公共卫生和临床实践指南,无语言限制。
在指南中很难找到用于评估证据质量和制定建议的系统的详细描述。我们观察到各组织之间以及组织内部在制定关于HCTDS的建议方面存在很大差异。24%的指南未考虑健康益处和危害,仅根据检查准确性做出决策。我们未发现描述涉及针对医疗问题进行检查的主要潜在护理途径的指南。此外,我们未发现系统评估、描述和引用将检查准确性与对患者重要的结果联系起来的证据的指南。
在制定关于检查使用的建议时所采用的流程和考虑的因素存在相当大的差异。这种差异可能是我们在针对相同病症的检查建议中观察到的分歧的原因。